Home
Storia in 1 fonti
Natera Secures Landmark Japan Nod For Signatera In Colorectal Cancer - Natera (NASDAQ:NTRA)
Natera won Japan approval for Signatera in colorectal cancer, paving the way for a commercial launch by 2026.
Raccontata da
benzinga.com
Timeline cronologica
- ·
Why Is Natera Stock Gaining Tuesday? - Natera (NASDAQ:NTRA)
Natera (NTRA) stock rallies following a key NCCN guideline update for Signatera. Also, check out the full NTRA stock analysis.
- ·
Natera Secures Landmark Japan Nod For Signatera In Colorectal Cancer - Natera (NASDAQ:NTRA)
Natera won Japan approval for Signatera in colorectal cancer, paving the way for a commercial launch by 2026.